Xibo Zhao
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
KIF26B and CREB3L1 Derived from Immunoscore Could Inhibit the Progression of Ovarian Cancer.
Journal: Journal of immunology research
Published: November 22, 2023
METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Journal: Journal of translational medicine
Published: February 01, 2023
Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis.
Journal: International journal of molecular sciences
Published: December 16, 2022
Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin.
Journal: Mediators of inflammation
Published: October 27, 2022
Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis.
Journal: Journal of immunology research
Published: October 26, 2022
Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer.
Journal: Frontiers in genetics
Published: November 15, 2021
Identification and Analysis of Potential Autophagy-Related Biomarkers in Endometriosis by WGCNA.
Journal: Frontiers in molecular biosciences
Published: July 17, 2021
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.
Journal: Frontiers in cell and developmental biology
Published: January 14, 2021
Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms.
Journal: Frontiers in cell and developmental biology
Published: October 05, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026